Hansoh Pharmaceutical Group Co., Ltd. (HNSPF)
4.25
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 25.77B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -4.11% |
| Valuation | |
| PE Ratio | 26.78 |
| PE Ratio (Forward) | |
| PS Ratio | 11.35 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0364 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, CNS diseases; metabolic and other diseases. The company was founded by Hui Juan Zhong on December 2, 2015 and is headquartered in Shanghai, China. |
| URL | http://www.hspharm.com |
| Investor Relations URL | N/A |
| HQ State/Province | Shanghai |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Mid Cap Core |
| Next Earnings Release | Apr. 01, 2027 (est.) |
| Last Earnings Release | Aug. 26, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 24, 2026 |
Profile
| Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, CNS diseases; metabolic and other diseases. The company was founded by Hui Juan Zhong on December 2, 2015 and is headquartered in Shanghai, China. |
| URL | http://www.hspharm.com |
| Investor Relations URL | N/A |
| HQ State/Province | Shanghai |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Mid Cap Core |
| Next Earnings Release | Apr. 01, 2027 (est.) |
| Last Earnings Release | Aug. 26, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 24, 2026 |